Wave Life Sciences Company

WaVe Life Sciences is leading a revolution in nucleic acid therapeutics and was founded on the core principle that medicines should possess precisely controlled molecular structures. We and our strategic partners are advancing a portfolio of stereopure drug candidates that target underlying biology across a wide range of human diseases. WaVe maintains R&D facilities in Boston and Japan and was founded by two world-renowned scientific leaders, Gregory Verdine and Takeshi Wada. Dr. Verdine is an Erving Professor of Chemistry in the Harvard University Departments of Stem Cell and Regenerative Biology, Chemistry and Chemical Biology, and Molecular and Cellular Biology. Dr. Wada is a professor at Tokyo University of Science, Faculty of Pharmaceutical Sciences and Department of Medicinal and Life Science.
Technology: Biotechnology, Health Care, Medical Device
Industry: End-to-end drug development, end-to-end drug development
Headquarters: Boston, Massachusetts, United States
Founded Date: 2012-01-01
Employees Number: 101-250
Funding Status: IPO
Investors Number: 10
Total Funding: 174000000
Estimated Revenue: $1M to $10M
Last Funding Date: 2018-02-20
Last Funding Type: Post-IPO Equity

Visit Website
info@wavelifesci.com
https://www.twitter.com/wavelifesci
Register and Claim Ownership